Authors
Latest:
Healthcare’s Digital Transformation Improves Lives, Not Just EfficienciesCOVID-19 sped up healthcare’s digital transformation. The 20-minute telehealth visit can mean less unpaid time off from work and the difference between seeking care and putting food on the table. Care-at-home programs can reduce the risks associated with hospitalization, such as hospital-acquired infections.
Latest:
Why the Future of Health Care is MobileFive years ago, health care providers didn’t see mobile as a priority or a necessary tool in improving the patient experience. The pandemic changed that.
Latest:
Optimizing the Management of TRDDrs Steven Levine, Patricia Ares-Romero, Samuel Nordberg, Martin Rosenzweig, and Carrie Jardine share insight on the future treatment landscape for TRD.
Latest:
Medicaid Plans Need to Prioritize Maternal, Infant TelehealthAs payer and provider organizations look to improve health outcomes around the far-reaching impacts of the pandemic, they must consider the unique needs of some of our most vulnerable populations, such as new and expecting mothers and their infants.
Latest:
Future Predictions for Intravenous and Subcutaneous BiologicsAn expert in the field of rheumatology predicts how the treatment landscape will evolve for intravenous and subcutaneous therapies.
Latest:
Enterprise Imaging: A Necessity – Not a Luxury – for Hospitals & Health SystemsEnterprise imaging platforms would enable organizations to consistently and optimally capture, index, manage, store, distribute, view, exchange and analyze all clinical imaging and multimedia content, enhancing patients’ electronic health records.
Latest:
Takeaways from Senate Hearing on Semaglutide PricingNovo Nordisk said it’s open to discussions with PBMs based on their commitments that a lower semgalutide list price would not impact formulary coverage.
Latest:
Unlocking the Hidden Potential of Modern Care ManagementHealth plans must embrace real-time member awareness, timely clinical context and actionable insights to realize the benefits of care management.
Latest:
Survey: Part B Price Negotiation Could have Significant Impact on ProvidersProviders also have concerns about being able to stock certain medications, which would have a negative impact on their patients, according the Avalere Health survey.
Latest:
Pressure on Patient Assistance Programs | Predictions for 2025Predictions for 2025 by Tracy Baroni Allmon, J.D., vice president of Market Access and Policy at Magnolia Market Access.
Latest:
Closing Insights: The Future of Cemiplimab in NSCLC and BeyondPanelists discuss how, as new data on cemiplimab and other checkpoint inhibitors emerge, the treatment pathway for cancers like non-small cell lung cancer (NSCLC) is expected to evolve toward more personalized, targeted approaches. This will enhance survival outcomes, refine patient selection and optimize therapy regimens.
Latest:
Digital Transformation is the Revolutionary Change Healthcare NeedsDue to one of the most challenging global crises in living memory and one that presented an acute challenge for the medical community, healthcare providers find themselves operating within an uncertain landscape. They are still managing the fallout of COVID-19 while also planning for the future.
Latest:
Precision Medicine vs Trial and Error: Why Pharmacogenomics is Increasingly RelevantPharmacogenomics looks at how genetic influences affect an individual’s response to therapeutic medications.
Latest:
Closing the Gap With Virtual Care Services: Reimagining the Delivery of HealthcareThe delivery of care model needs to scale across the community settings while servicing the unique needs of each patient.
Latest:
CMS’ RADV Strategy Will Reverberate Throughout Health Plan OperationsTo prepare for CMS’ new risk adjustment data validation (RADV) strategy, Medicare Advantage plans must take a coordinated, organization-wide approach.
Latest:
Study: Medicaid Coverage Uneven for Gene TherapiesRecent study finds that Medicaid coverage for some of the first gene and cell therapies was at times delayed and not consistent with federal requirements.
Latest:
Digital Patient Engagement: Helping Uninsured Americans Gain Access to CareIdentifying the right payer before a healthcare service is provided and billing on time, reduces costs, prevents bad debt and maximizes reimbursements and revenue.
Latest:
Acute Hospital-at-Home Holds Promise for Hospitals Facing Staffing ShortagesOrganizations setting up hospital-at-home programs need to be aware of the associated risks and mitigation best practices.
Latest:
Reimagining healthcare payer operations: the power of process intelligenceHow AI-powered technology and its data-driven insights improve payer operations and reimburse providers faster.
Latest:
Getting Real About Health EquityCMS and state officials are using payment incentives, data collection and program requirements to start edging the lofty ideals of health equity toward reality.
Latest:
Collaborating to Support Better Outcomes Through Value-Based CareEngaging with payers in collaborative arrangements is critical for achieving quality outcomes at lower cost, while ensuring financial health for providers during good times and bad.
Latest:
Why Timing Matters When It Comes to PBM ContractingPlan sponsors should begin evaluation of PBM performance at least a year before the contract expires, say lawyers with expertise in PBM contracting.
Latest:
Health Plans Are Managing More Data Than Ever Before. How to Ensure It’s Usable.Health plans need to consider regulations and keep healthcare data secure to take full advantage of its enormous potential to broaden and reshape timely, effective delivery of care.
Latest:
The Future of the Growing Medication Adherence MarketPatients with chronic conditions like asthma, diabetes, and cardiovascular disease often require emergency attention and hospitalization due to non-adherence, resulting in higher treatment costs.
Latest:
Clinical Decision Support Can Help Identify Common Drugs Linked with Increased Arrhythmia and Sudden Death RiskResearch has linked many drugs to QT prolongation and decision support tools could alert clinicians to the risk and guide prescribing decisions to safer alternatives.
Latest:
Pharma: Striding Towards the Digital-only Reality with AIAs industries across the board move towards a digital-only world, pharma companies must account for the different technologies that are transforming the R&D process.
Latest:
Why Timing Matters When It Comes to PBM ContractingPlan sponsors should begin evaluation of PBM performance at least a year before the contract expires, say lawyers with expertise in PBM contracting.
Latest:
Value-Based Decision-Making in Metastatic Breast CancerIn this Managed Healthcare Executive® KCast, Ian Krop, M.D., Ph.D., oncologist and associate professor of medicine at Dana-Farber Cancer Institute in Boston, and Debra Patt, M.D., Ph.D., MBA, executive vice president at Texas Oncology in Austin, provide key insights into the value-based care model for patients with HER2-positive metastatic breast cancer (mBC). This article summarizes the highlights of the discussion.
